While the meetings confirmed the significant clinic expansion opportunity, the analysts stated that their numbers remain unchanged until there is more clarity on the pace of expansion. The report emphasized the strength of OrthoPediatrics' existing U.S. pediatric hospital reach and OPSB's clinic expansion potential. The proven OPSB clinic model and innovation pipeline were also noted as factors positioning the company for above-average growth in the future. In other recent news, OrthoPediatrics Corp. reported its first-quarter financial results, revealing a revenue increase that surpassed consensus estimates, though its adjusted EBITDA did not meet expectations. Despite this, the company has revised its revenue forecast upwards for 2025 while maintaining its adjusted EBITDA guidance.